INTRODUCTION:

Known locally as amla or Indian gooseberry, Phyllanthus emblica L. (Phyllanthaceae) is a remarkable herb that is frequently employed in Indian Ayurvedic systems. It is utilized in the Unani medical system in addition to Indian Ayurveda. Because of its high nutrient content, P. emblica may be a valuable dietary source of minerals, vitamin C, and amino acids.¹ The majority of tropical and subtropical countries are home to Phyllanthus emblica Linn., a member of the Euphorbiaceae family. It plays a vital role in important medicinal preparations including triphala and chyawanprash, a general tonic that improves physical and mental well-being in individuals of all ages.² According to pharmacological research, P. emblica possesses anti-inflammatory, anti-cancer, immunomodulatory, cytoprotective, antiviral, anti-jaundice, anti-dyslipidemic, anti-apoptotic, hepatoprotective, nephroprotective, and anti-diabetic properties.³ It is widely used as a stimulant to restore the body's lost vitality and endurance. The fruit is used as a diuretic, laxative, liver tonic, refrigerant, stomachic, restorative, alterative, antipyretic, hair tonic, to prevent peptic ulcers and dyspepsia, and as a digestive aid. It can be used alone or in conjunction with other herbs to treat a variety of illnesses, including fever and the common cold. Additionally, plant parts have gastroprotective, antimicrobial, antiulcerogenic, hypolipidemic, and chemopreventive qualities.⁴

It is also known for its antimicrobial, anti-tussive, anti-atherogenic, adaptogenic, cardioprotective, chemopreventive, radioprotective activities⁵. The therapeutic potential of P. emblica is largely attributed to its rich phytochemical profile. It is a rich natural source of vitamin C, Embilicanin A, Emblicanin B, Phyllaemblicin B, Punigluconin and also consists of Ellagic acid, Chebulinic acid, Chebulagic acid, Gallic acid, Quercetin, Apigenin, Leutolin, Corilagin. etc.” which contribute to its broad pharmacological effects.⁶

Phyllanthus emblica, also referred to as amla or Indian gooseberry, has been used for a long time in Ayurvedic and traditional medical systems, but it is still underutilized in the modern clinical and pharmaceutical fields. Although the plant is well known for its strong antioxidant properties, there is mounting evidence that it also has a wide range of other bioactivities, such as anti-inflammatory, anti-diabetic, cardioprotective, and anticancer properties. However, due to a lack of clinical validation, variations in phytochemical content among extracts, and inadequate integration with new biomedical technology, P. emblica's full therapeutic potential is still largely untapped. Furthermore, its prospective uses in nanobiotechnology, like targeted medication delivery and environmentally friendly nanoparticle manufacturing, are just now being investigated.

In addition to offering a thorough summary of P. emblica's phytochemical diversity and range of pharmacological actions, this review aims to identify important knowledge gaps and new translational opportunities that must be filled in order to fully realize the plant's multifaceted therapeutic potential.

Main Text:

1. Botanical Description and Traditional Applications:

1.1 Taxonomy and Classification:⁷

Kingdom: Plantae.

Phylum: Angiosperma [flowerimg plant]

Class: Magnoliopsida

Order: Malpighiales.

Family: Phyllanthaceae

Genus: Phyllanthus

Species: emblica

1.2 Botanical Characteristics:

A small to moderately sized tree, P. emblica L. has greenish-grey bark and greenish-yellow flowers that are arranged in axillary clusters. All of the branchlets face the same plane and are alternately superposed. More than 100 leaves are grouped in the branchlets, which can reach a length of 40cm.⁸ The plant produces spherical, ridged fruit. It is separated into six sections, each of which has a stone. The stones range in diameter from 1.8 to 2.5cm. The fruit is tiny and spherical with a rough covering. There are six seeds inside. The fruit is spherical and yellow, and it looks good. It has an astringent and sour flavor.⁹

1.3 Medicinal and Traditional Uses:

Ayurvedic writings emphasize the numerous health benefits that amla offers. They are:

Improves food absorption: Amla-berry can improve food digestion, absorption, and assimilation when taken regularly. Those who take it observe that they prefer the way food tastes. All thirteen digestive fires (Agni) are enhanced by it. Additionally, it enhances iron absorption for healthy blood.¹⁰

Antimicrobial Activity:

According to antibacterial and antifungal screening tests, the fruit extract of Phyllanthus emblica (Linn.) exhibited modest antimicrobial activity.¹¹

Hyperlipidemic effects:

Improved lipid profiles have been reported in several animal studies. Through an increase in hepatic HMG-CoA reductase, flavonoid extracts from Emblica fruits reduced the synthesis of cholesterol and improved its breakdown^.12 The analgesic and antipyretic properties of alcohol and Emblica fruit aqueous extracts were evaluated in mice. With the exception of emblica's lack of action in the thermal pain model, the results were comparable to those of aspirin. ¹³

2. Phytochemical composition of Phyllanthus emblica:

Phyllanthus emblica is renowned for its rich and diverse phytochemical profile, which varies among its different parts (leaves, seeds, fruits, bark, and flowers). Below is an overview of the key bioactive constituents identified in each part:

Leaves:

Fatty acids (such as isopropyl palmitate, γ-linolenic acid, 8,11-octadecadienoic acid methyl ester, 2-methylhexadecanoic acid, and linolenic acid) and alkaloids (such as 1,3-dimethylindole) were detected in the methanol extract of P. emblica dry leaves.¹⁴. Phenolic acids (such as chebulagic acid and 3,6-di-O-galloylglucose) and fatty acids (such as octadecanoic acid, 9,12-octadecadienoic acid, hexadecenoic acid, 9-hexadecenoic acid, and tetradecanoic acid) were detected in the ethanol extract of P. emblica dry leaves. Flavonoids (e.g. (S)7-O-(6"-O-trans-p-coumaroyl) -eriodictyol-β-D-glucopyranoside, (S)-eriodictyol 7-O-(6"-O-galloyl)-β-D-glucopyranoside); terpenes (like sativen, δ-guaiene, and caryophellene); long-chain aldehyde (like octadecanal); phenolic glycoside (like 2-(2-methylbutyryl)phloroglucinol 1-O-(6"-O-β-D-apiofuranosyl)-β-D-glucopyranoside); and alcohols (like 1-hexadecanol, 11-tetradecen-1-ol, and 2-furanmethanol).^15,16,17. Phenolic acids (such as gallic acid, chlorogenic acid, caffeic acid, syringic acid, ellagic acid, coumaric acid, ferulic acid, cinnamic acid, vanillin, and propyl gallate), flavonoids (such as catechin, rutin, naringenin, quercetin, and kaempferol-3-O-β-D-glucoside), and phytosterol (such as stigmast-4-en-3-one) were detected in n-butanol and ethyl acetate extracts of P. emblica dried leaves.¹⁸

Barks:

Total phenols, flavonoids, and tannins were detected by quantitative phytochemical screening of PEE. Gallic acid, ellagic acid, polyphenols, and flavonoids are responsible for the PEE's antioxidant and hepatoprotective properties.¹⁹ Additionally, it contains phytochemicals such as luteol, leucodelphinidin, and β-sitosterol.²⁰

Fruits:

Phyllanthus emblica extract ethanol has high quantities of flavonoids and total phenol, as well as antioxidant properties. According to the results, EEPE contains flavonoids such leucine, kaempferol, myricitrin, myricetin, betaine, trigonelline, and quercetin.²¹ The majority of the phenolics found in emblica fruit were present in the ethyl acetate fraction. Reverse-phase HPLC was used to purify six phenolic compounds, which were then identified by UV–V is spectrophotometry, MS and NMR spectroscopy, and comparison with existing literature as geraniin, quercetin 3-b-D-glucopyranoside, kaempferol 3-bD-glucopyranoside, isocorilagin, and quercetin, respectively. Furthermore, the majority of the refined substances exhibited potent antioxidant and radical scavenging properties. Therefore, one of the ways that these substances are utilized in traditional medicine may be through the antioxidant activity of emblica fruit.²²

Seeds:

According to the findings, seed extracts had substantial levels of flavonoids and tannins, with 1016.25 mg QE and 126.71 mg TAE per gram extract, respectively. Seed extract may be cytotoxic to MCF-7 cell lines and exhibit antioxidant properties. This study offers information on how P. emblica seeds can be used to enhance the value of products like herbal medicines, supplemental foods, and cosmetics. Thus, the goal of future research is to examine the phytochemicals in P. emblica seeds in greater detail, both qualitatively and quantitatively.²³ Additionally, it highlights Emblica seeds' significant ability to inhibit atherosclerotic foam cells.²⁴

Flowers:

Gallic acid derivatives, flavonoid glycosides, and tannins, based on their fragmentation patterns, were identified from P. emblica flowers. Spermidine compounds were identified. Optimization of HPTLC and HPLC methods marked the presence of corilagin as a major compound, followed by FT-IR and NMR spectral methods. Moreover, treatment with hydromethanolic extract of P. emblica flowers resulted in decreased levels of proinflammatory cytokines, TNF-α, IL-1β, and IL-6, alongside modulation of nuclear factor-κB activity in lipopolysaccharide-induced THP-1 macrophages.²⁵

3. Pharmacological Properties:

3.1 Antioxidant Activity:

Plant antioxidants found in emblica fruit may find application in the culinary, cosmetics, and pharmaceutical industries. The main active ingredient that may be in charge of the potent antioxidant action is phenolics. Nonetheless, a more thorough examination of the relationship between the antioxidant activity and the distinct phenolic components found in emblica fruit is required.²⁶ The methanolic leaf extract of P. emblica showed significant DPPH radical, nitric oxide, and lipid peroxidation scavenging capabilities in an in vitro antioxidant evaluation. According to the findings, PELE may be able to control cellular reactions and preserve the pulmonary tissues' functional integrity.²⁷. It is suggested that amla seed coat extracts are a rich natural antioxidant source that can be used extensively in the creation of nutraceutical products that promote health. More bioactive components in the ethanolic bark extract than in the aqueous bark extract gave it the ability to scavenge free radicals, which is crucial for avoiding oxidative stress.²⁸

3.2 Anticancer Properties:

P. emblica fruits possess a strong anti-AP-1 and anti-HPV activity in cervical cancer cells and thus support the development of herbal formulation(s) containing P. emblica alone or in combination with other herbal anti-HPV activities that have been recently identified, such as curcumin, berberine, and Bryophyllum pinnata to control HPV infection and cervical cancer. P. emblica fruits have a strong antioxidant activity that is ascribed to their constituent polyphenols like ellagitannins, ellagic acid, emblicanin, furosin, mucic acid, phyllantidin, phyllembin, and trigalloyl glucose, which may directly affect the redox status of cervical cells.^29,30 Using an MTT (3- (4, 5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) method, the antiproliferative activities of 18 major compounds—including four norsesquiterpenoids (1–4) and 14 phenolic compounds (5–18) that had previously been isolated from Phyllanthus emblica, as well as a main constituent, proanthocyanidin polymers (19), discovered at this time from the roots—were assessed against MK-1 (human gastric adenocarcinoma), HeLa (human uterine carcinoma), and B16F10 (murine melanoma) cells. In comparison to HeLa and MK-1 cell growth, B16F10 cell growth was more strongly inhibited by all of the phenolic compounds, including the main components 5–8 from the fruit juice, 8, 9, and 12 from the branches and leaves, and 19 from the roots. While the roots' aglycon 1 and monoglucoside 2 did not exhibit any inhibitory action against these tumor cells, norsesquiterpenoid glycosides 3 and 4 showed notable antiproliferative properties.³¹

3.3 Antiviral Properties:

Antiviral and virucidal properties of Phyllanthus-derived compounds showed promising results as controlling agents against viral infections in different cell models, particularly in the viral replication and translation processes.³² The strongest inhibitory action against HIV-1 RT was found in P. emblica. The results showed that these plants contained anti-HIV properties.³³

3.4 Antihyperlipidemic properties:

Given its accessibility, affordability, and other positive effects, amla can be used safely to treat mild to moderate instances of hyperlipidemia.³⁴ Numerous mechanisms, such as enhanced PPAR expression, increased LDL-R expression on hepatocytes, decreased PCSK9 levels, improved hepatic lipolytic activity, and decreased lipogenic enzymes, have validated E. officinalis' anti-hyperlipidemic efficacy. E. officinalis reversed the changes in lipid metabolism brought on by a high-fat diet, reduced hepatic oil infiltration, and reduced oil buildup in the aortic intimal wall. One of the main phytoconstituents in E. officinalis, gallic acid, has been identified as the bioactive component that gives the plant its anti-hyperlipidemic properties.³⁵

3.5 Anti-inflammatory Properties and Analgesic Properties:

Two PEE-derived anti-inflammatory active monomers, gallic acid and fisetin, effectively reduced the synthesis of NO and other inflammatory components.³⁶ The THP-prepared standardized water extract from P. emblica fruit appears to have analgesic and anti-inflammatory properties more akin to NSAIDs than steroidal medications. One of P. emblica's primary modes of action may be its inhibitory influence on the production and/or release of inflammatory or pain mediators.³⁷

3.6 Anti-diabetic effects:

Different concentrations of quercetin isolated from P. emblica showed remarkable antihyperglycemic effects and potent defense mechanisms in STZ-induced diabetic rats.³⁸ The experiments carried out in this study showed positive hypoglycemic activity of the plant. However, further investigation is needed to assess whether or not Phyllanthus emblica extracts may be used commercially.³⁹

3.7 Neuroprotective Effects:

P. emblica contains high polyphenolic compounds associated with neuroprotective effects by reducing neuroinflammation and neurodegeneration caused by oxidative stress.⁴⁰ EEPE fruits showed marked beneficial effects for improving learning, memory, and antioxidant potential. Among ripe and unripe fruits, significant cognitive-enhancing effects were observed by unripe fruit, which is comparable with the standard. Thus, this plant extract can be useful in the treatment of various cognitive disorders, dementia, and neurodegenerative disorders, especially AD.⁴¹

4. Toxicological Profile and Safety Evaluation:

Rats given oral LD₅₀ > 5000mg/kg showed no signs of organ damage, aberrant behavior, or death.⁴² All extracts, whether standardized or aqueous, have modest acute toxicity; nevertheless, the common aqueous extract has an LD₅₀ > 5000mg/kg. Phyllanthus emblica extracts do not produce organ toxicity or haematological abnormalities when used within therapeutic limits, according to sub-chronic and chronic investigations that involve repeated dosing over weeks or months.⁴³

4.2 Side Effects and Contraindications:

Few phytosterol compounds from P. emblica have been reported to have cytotoxic effects in tumor and non-tumor cell lines. Otherwise, no reported toxicity has been observed. Contraindications have not been identified. Information regarding safety and efficacy in pregnancy and lactation is lacking.⁴⁴

5. Therapeutic Formulations and Drug Development:

5.1 Extract Types: Aqueous, Ethanolic, and Methanolic:

Aqueous Extract:

In people with metabolic syndrome (MetS), endothelial function has been significantly improved by a standardized aqueous extract of Phyllanthus emblica. A lower reflection index and improvements in important biomarkers, such as elevated glutathione (GSH) and nitric oxide (NO), as well as lower levels of malondialdehyde (MDA) and high-sensitivity C-reactive protein (hsCRP), were used to illustrate this. Furthermore, notable enhancements were noted in lipid profiles. When compared to a placebo, both the 250 mg and 500 mg twice-daily doses were effective; however, the larger dose was more effective. The extract's good tolerability points to its potential as a supplement to traditional treatments for MetS. To confirm these results, more extensive research is necessary.⁴⁵

Strong antioxidant activity has been shown by the Phyllanthus emblica fruit aqueous extract made by the Thai Herbal Pharmacopoeia. It efficiently lowers ferric ions, scavenges free radicals, and prevents the generation of reactive oxygen species (ROS). These characteristics point to its possible use in hepato-, cyto-, and radioprotection—the defense against damage caused by oxidative stress.⁴⁶ According to the Thai Herbal Pharmacopoeia (THP), the standardized aqueous extract of Phyllanthus emblica fruit has strong analgesic and anti-inflammatory properties. By preventing the production or release of inflammatory and pain mediators, it seems to have an action comparable to that of non-steroidal anti-inflammatory medications (NSAIDs).⁴⁷ The antihepatic fibrosis effect of AEPE in vivo and proved that AEPE can reduce CCl₄-induced liver fibrosis and improve liver function by reducing ECM accumulation, HCS activation, oxidative stress, and inflammatory response.⁴⁸

Ethanolic Extract:

Flavonoids are present in Phyllanthus emblica extract ethanol, which also has high quantities of flavonoids and total phenol and antioxidant activity.⁴⁹ Phyllanthus emblica fruit ethanolic extract exhibits potent antibacterial activity and performs well when used in combination therapy with several antibiotics.⁵⁰It is advised to use the 95% ethanol extract of P. emblica in daily health drinks or food since it exhibited greater antioxidant, anti-inflammatory, and neuroprotective action than the other extracts.⁵¹

Methanolic Extract:

The phenolic content and antioxidant activity of methanolic extracts of Emblica fruit from six different Chinese regions varied. The highest concentrations of proanthocyanidins, flavonoids, and total phenolics were found in the Huizhou sample. All of the extracts showed potent antioxidant and radical-scavenging properties; the Huizhou and Chuxiong samples fared similarly to quercetin and BHA. These results imply that the bioactive component content and antioxidant potential of Emblica fruit are both strongly influenced by geographic origin. Although further research is required to fully understand the roles of various phenolic components, phenols are probably the main contributors to its antioxidant activity. Emblica exhibits potential as a natural antioxidant source for use in medicinal, cosmetic, and food applications.⁵²

5.2 Commercial Products Containing Phyllanthus emblica:

Phyllanthus emblica has been incorporated into various commercial herbal preparations due to its proven therapeutic properties. These goods come in the following forms: juices, oils, syrups, powders, and capsules. Among the examples are:

Table 1:

Product/Brand	Form	Key Benefits
CAPROS® (Natreon Inc.)	Standardized fruit extract capsules (250mg/500mg, aqueous)	Improves endothelial function, reduces inflammation in metabolic syndrome
TRI-LOW®	Capsule/Bulk Extract	Lipid management, anti-inflammatory
Amlamax™	Capsule	Cholesterol management
Dabur Amla Juice	Liquid Juice	General health, digestion, detox

5.3 Nano Formulations and Advanced Drug Delivery Systems:

1. Phytosynthesized Metal Nanoparticles (Ag, Fe₃O₄, Pd, Au):

Produced by employing P. emblica extract at pH 7.4 and pH 10 to green reduce AgNO₃.Zeta potential: ~-25mV, average size: ~15–20nm, exhibits good hemocompatibility and safety in rats, along with potent antibacterial activity against Salmonella typhi, E. coli, and S. aureus, among others.⁵³

2. Iron Oxide Nanoparticles (IONPs):

In comparison to uncoated iron oxide nanoparticles, those coated with P. emblica extract are smaller, more evenly distributed, and more efficient at causing ROS-mediated apoptosis in A549 lung cancer cells.⁵⁴

3. Gold Nanoparticles (AuNPs):

AuNPs that were green-synthesised with P. emblica plus Through autophagy suppression and mitochondrial malfunction, Bifidobacterium lactis causes AGS gastric cancer cells to undergo apoptosis.⁵⁵

4. Polymeric and Lipid Nanoformulations: Nano‑Simplicial and Chitosan-Based Systems:

A biodegradable delivery system is provided by chitosan–casein nanoparticles encasing amla extract, which exhibit strong antibiofilm and antibacterial efficacy against Pseudomonas aeruginosa.⁵⁶Ionic gelation-based nanosimplicia suspensions (chitosan + TPP) can suppress bacteria (S. aureus, E. coli) by 15–16 mm and produce a protein-denaturation-based anti-inflammatory response of about 30% that lasts for 30 days.⁵⁷

6. Clinical Studies and Human Trials

Dermatological Application: Acne Vulgaris: In a placebo-controlled comparative clinical study, the trial drug Amalaki capsule has effectively improved skin hydration and reduced Acne count and severity in Acne vulgaris patients. An increase in TAC level and a decrease in IgE level show that the Amalaki capsule has a potent antioxidant effect.⁵⁸

Cardiometabolic Benefits: According to poor certainty of evidence, Emblica officinalis fruit extract raised HDL-C levels and decreased total cholesterol and LDL-C levels when compared to a placebo. However, it did not affect serum triglyceride levels. To further support the use of E. officinalis extract in patients with dyslipidemia, bigger sample size trials that directly compare it to statins—preferably local data—are required.⁵⁹

Endothelial Function and Oxidative Stress (Type 2 Diabetes): Without appreciably altering laboratory safety measurements, atorvastatin and P. emblica both markedly enhanced endothelial function and decreased indicators of oxidative stress and systemic inflammation in individuals with type 2 diabetes mellitus.⁶⁰

6.2 Limitations and Future Scope:

Because of its high vitamin C concentration, varied pharmacological characteristics, and abundant antioxidant content, Phyllanthus emblica has great medicinal and nutritional potential. However, there are some restrictions that prevent its wider use, even with its established and new uses. Standardizing its bioactive components, which might differ depending on factors including geographic origin, growing methods, and processing techniques, is one of the main challenges. Its acceptability in mainstream medicine is further hindered by a lack of clinical validation and conflicting scientific data about its effectiveness in human patients. Stability problems also make it difficult to formulate in medicines and nutraceuticals, particularly when it comes to its vitamin C concentration. Additionally, consumers' acceptance of food and beverage products may be impacted by the harsh and astringent flavor of amla. In order to improve its stability and bioavailability, future research should concentrate on sophisticated extraction methods, thorough clinical investigations, and the creation of innovative administration systems. If these present issues are sufficiently resolved through interdisciplinary scientific cooperation, Phyllanthus emblica has enormous potential for growth in the pharmaceutical, functional food, and cosmetic industries, given the growing interest in plant-based therapies and preventive healthcare around the world.

7. Challenges and Future Perspectives:

Phyllanthus emblica is traditionally used to address numerous disorders along with food ingredients. In spite of the fact that various modern research techniques have been established to validate the medicinal uses of P. emblica traditionally, some aspects including its contents and its applications need to be further investigated scientifically. For example, only a few studies reported P. emblica antimalarial, antiviral, anti-venom, and insecticidal properties. Some of its properties were also reported with other parts of P. emblica. Accordingly, it is imperative that the agents, molecules or parts mediating its therapeutic activities be identified. Additionally, more extensive research, such large-scale evidence-based trials, must be done to examine the medical benefits of P. emblica.⁶¹ To stop resource loss and preserve ecological balance, it is crucial to scale up sustainable cultivation and guarantee genetic diversity, especially in areas like India's Western Ghats. ⁶²

Looking to the future, interdisciplinary collaboration offers promising solutions: applying advanced biotechnological methods and innovative extraction processes (e.g., encapsulation, nanoemulsion) can stabilize bioactive constituents and improve bioavailability. Well,‑designed randomized controlled trials are urgently needed to define therapeutic efficacy, dosing guidelines, and safety profiles in humans. Additionally, the development of patentable amla-derived compounds could incentivize pharmaceutical interest, particularly in oncology.⁶³

On the business side, incorporating fair trade agreements, agroforestry projects, and sustainable sourcing methods can empower local communities and guarantee supply chain integrity. Additionally, the export and uptake of functional foods, cosmeceuticals, and nutraceuticals based on amla will be facilitated by the harmonization of regulatory regimes around the globe. Phyllanthus emblica has the potential to greatly increase its medicinal, nutritional, and commercial influence on a global basis if these issues are proactively resolved by thorough research, concerted policy initiatives, and ethical entrepreneurship.

Recent Contributions from Asian Journal Publications on Phyllanthus emblica:

Recent studies published in Asian journals (AandV group) provide additional experimental evidence supporting the antimicrobial, anti-inflammatory, antioxidant, safety, and formulation aspects of Phyllanthus emblica preparations. The following insights are noteworthy:

Antimicrobial Exploration:

Ethanol extracts and fractions of P. emblica fruit exhibited potent antibacterial activity against pathogens such as Bacillus cereus and Shigella dysenteriae, with ethyl acetate fractions showing low MIC and MBC values.⁶⁴

Anti-inflammatory Nanosuspension Formulation:

P. emblica fruit-derived nanosimplicia suspension, formulated via ionic gelation, demonstrated significant anti-inflammatory activity (29.7% inhibition in protein denaturation assay) and notable antibacterial effects.⁶⁵

Topical Herbal Lotion:

An herbal lotion combining alcoholic extracts of P. emblica and Allium sativum demonstrated promising antioxidant efficacy and formulation stability.⁶⁶

Fermentation and Safety:

Fermented fruit juice of P. emblica was evaluated for biological safety and found suitable for potential therapeutic or nutraceutical use.⁶⁷

Nanotechnology Applications:

P. emblica extract facilitated the green synthesis of silver nanoparticles exhibiting notable anti-inflammatory and antifungal properties against dermatophytes.⁶⁸

Ethnomedicinal and Unani Review:

P. emblica has traditional applications, bioactive constituents, and pharmacological activities with an emphasis on Unani medicine.⁶⁹

Neurobehavioral Benefits:

An aqueous fruit extract of P. emblica, in tandem with Terminalia chebula, demonstrated antidepressant-like activity in experimental animal models, implicating monoaminergic modulation.⁷⁰

Therapeutic Applications in Green Pharmacy:

Emblica officinalis has anti-inflammatory, adaptogenic, cardioprotective, gastroprotective, and neuroprotective properties.⁷¹

Ayurvedic Polyherbal Formulations:

P. emblica was shown to exert antidiabetic and cardioprotective effects alongside stress-mitigating benefits.⁷²

Formulation Science and Novel Delivery:

Studies emphasize nanosuspensions and green formulations of P. emblica for improved bioavailability and enhanced pharmacological actions.

CONCLUSION:

In summary, Phyllanthus emblica, also referred to as Indian gooseberry or amla, is a very useful medicinal plant with a wide range of therapeutic benefits that are backed by both contemporary scientific research and traditional wisdom. Numerous pharmacological actions, such as anti-inflammatory, antibacterial, antidiabetic, hepatoprotective, cardioprotective, and anticancer properties, are supported by its strong antioxidant activity, which is primarily ascribed to its high vitamin C and polyphenol content. Notwithstanding its enormous promise, obstacles like inconsistent phytochemical composition, a dearth of human trials, and a lack of standardized formulations continue to restrict the practical translation of these advantages. To fully utilize its therapeutic potential, future research concentrating on component isolation, bioavailability increase, and clinical confirmation will be essential. Phyllanthus emblica is a viable option for additional research and incorporation into contemporary healthcare systems, given the growing interest in plant-based medicine and preventative health on a global scale.

LIST OF ABBREVIATIONS:

MS: Mass spectroscopy

NMR: Nuclear magnetic resonance

TAE: Tannic acid equivalent

QE: Quercitin equivalent

MCF-7-Michigan Cancer Foundation-7

HPTLC- High-Performance Thin-Layer Chromatography.

HPLC- High-Performance Liquid Chromatography

FT-IR- Fourier Transform Infrared Spectroscopy

TNF-Tumor necrosis factor

IL-1β- Interleukin 1 beta

THP-1-Tamm-Horsfall Protein-1

AP-1-Activator Protein 1

HPV- Human papillomavirus

HIV-1 RT- Human Immunodeficiency Virus Type 1 Reverse Transcriptase

PPAR- Peroxisome proliferator-activated receptor

LDL-R- low-density lipoprotein receptor

NO- Nitric oxide

THP- Tetrahydropyran

ECM- Extracellular matrix

HCS -Hepatic Cellular Steatosis

BHA- Butylated hydroxyanisole

ROS-Reactive oxygen species

TAC-Total antioxidant capacity

LDL-Low density lipoprotein

HDL-High density lipoprotein

ACKNOWLEDGMENT:

The authors of this article would like to express their gratitude to Dr. B. A. Vishwanath, Chairman of the Aditya Group of Institutions, Yelahanka, Bengaluru, for giving me access to use the college's research facilities and for providing me with the materials required.

CONFLICT OF INTEREST:

The authors declare that there is no conflict of interest.

REFERENCES:

1. Bashir Ahmad, Nabia Hafeez, Abdur Rauf, Shumaila Bashir, Huang Linfang, Mujeeb-ur Rehman, Mohammad S. Mubarak, Md. Sahab Uddin, Saud Bawazeer, Mohammad Ali Shariati, Maria Daglia, Chunpeng Wan, Kannan RR Rengasamy, Phyllanthus emblica: A comprehensive review of its therapeutic benefits, South African Journal of Botany 2021; 138: 278-310. https://doi.org/10.1016/j.sajb.2020.12.028

2. Bonthu VAD, Vatchavai B, Kunche TL, Konala JSP, Shaik S, Sattineedi P, Seelamsetti D. Phytoconstituents and pharmacological activities of Phyllanthus emblica. Int J Pharm Sci. 2024; 2(12): 1975-1986. doi:10.5281/zenodo.14462949

3. Prananda AT, Dalimunthe A, Harahap U, Simanjuntak Y, Peronika E, Karosekali NE, Hasibuan PAZ, Syahputra RA, Situmorang PC, Nurkolis F. Phyllanthus emblica: a comprehensive review of its phytochemical composition and pharmacological properties. Front Pharmacol. 2023 Oct 26; 14:1288618. doi:10.3389/fphar.2023.1288618. PMID: 37954853; PMCID: PMC10637531.

4. Naila H Alkefai, Aayeena Altaf, Zeeshan Altaf, Mir Khanam and Afshana Khan. Medicinal and Therapeutic Potential of Phyllanthus emblica (Amla-Indian Gooseberry): A Review Journal of Nutrition and Food .2023;13( 3)1-4. DOI: 10.35248/2155-9600.23.13.021

5. Saini R, Sharma N, Oladeji OS, Sourirajan A, Dev K, Zengin G, El-Shazly M, Kumar V. Traditional uses, bioactive composition, pharmacology, and toxicology of Phyllanthus emblica fruits: A comprehensive review. Journal of Ethnopharmacology. 2022; 282: 114570. doi: 10.1016/j.jep.2021.114570.

6. Swathi V, Suresh Kumar JN, Dharani Prasad P, Salma S, Rani M, Aslam SA, Tipsy K. A Review on Phyllanthus emblica: Antiinflamatory and Antioxidant Effect. Uttar Pradesh Journal of Zoology. 2023; 44(6): 23–32. DOI: 10.56557/UPJOZ/2023/v44i63451.

7. Vijaya Ambica Durga Bonthu, Bhaskararaju Vatchavai, Tejasri Lakshmi Kunche, Jyothsna Satya Priya Konala, Shafiya Shaik, Pujitha Sattineedi, Dhanusree. Phytoconstituents And Pharmacological Activities of Phyllanthus emblica. International Journal of Pharmaceutical Sciences. 2024; 2(12): 1975-1986. DOI: 10.5281/zenodo.14462949.

8. Gaire BP, Subedi L. Phytochemistry, pharmacology and medicinal properties of Phyllanthus emblica Linn. Chin J Integr Med. 2014 Dec 9. doi: 10.1007/s11655-014-1984-2. Epub ahead of print. PMID: 25491539.

9. Prananda AT, Dalimunthe A, Harahap U, Simanjuntak Y, Peronika E, Karosekali NE, Hasibuan PAZ, Syahputra RA, Situmorang PC, Nurkolis F. Phyllanthus emblica: a comprehensive review of its phytochemical composition and pharmacological properties. Front Pharmacol. 2023; 14: 1-20.doi:10.3389/fphar.2023.1288618. PMID: 37954853; PMCID: PMC10637531.

10. Singh E, Sharma S, Pareek A, Dwivedi J, Yadav S, Sharma S. Phytochemistry, traditional uses and cancer chemopreventive activity of Amla (Phyllanthus emblica): The Sustainer. Journal of Applied Pharmaceutical Science. 2011; 2(1): 176-83.

11. S.M. Moazzem Hossen, Mohi Uddin and Md. Raihan Sarkar. Medicinal potential of Phyllanthus emblica (Linn.) fruits extracts: biological and pharmacological activities. International Journal of Pharmacognosy. 2014; 1(5): 307-316. DOI: http://dx.doi.org/10.13040/IJPSR.0975-8232.IJP.1(5).307-16

12. Lanka S. A review on pharmacological, medicinal and ethnobotanical important plant: Phyllanthus emblica linn.(syn. Emblica officinalis). World Journal of Pharmaceutical Research. 2018; 7(4): 380-96. DOI:10.20959/wjpr20184-11103

13. Perianayagam JB, Sharma SK, Joseph A, Christina AJ. Evaluation of anti-pyretic and analgesic activity of Emblica officinalis Gaertn. Journal of Ethnopharmacology. 2004; 95(1): 83-85. DOI: 10.1016/j.jep.2004.06.020

14. Abdel-Hady H, Morsi EA, El-Wakil EA. In-vitro antimicrobial potentialities of Phyllanthus emblica leaf extract against some human pathogens. Egyptian Journal of Chemistry. 2022; 65(7): 701–707.doi:https://doi.org/10.21608/ejchem.2021.109577.4998

15. 15.Zhang YJ, Abe T, Tanaka T, Yang CR, Kouno I. Phyllanemblinins A−F, New Ellagitannins from Phyllanthus emblica. Journal of Natural Products. 2001; 64(12): 1527–1532. DOI: 10.1021/np010370g

16. Asmilia N, Yudha F, Abrar M, Rinidar R. Chemical compounds of Malacca leaf (Phyllanthus emblica) after triple extraction with N-hexane, ethyl acetate and ethanol. Hindawi. 2020. https://doi.org/10.1155/2020/2739056.

17. Mohamed TS, Refahya LA, Romeihb MH, Hameda MM, Ahmedb HO, El-Hashash MA. Chromatographic isolation and characterization of certain bioactive chemical ingredients of Phyllanthus emblica extracts and assessment of their potentials as antiviral and anticancer agents. Egyptian Journal of Chemistry. 2022; 65(1): 179–192.

18. Zhang YJ, Abe T, Tanaka T, Yang CR, Kouno I. Two new acylated flavanone glycosides from the leaves and branches of Phyllanthus emblica. Chemical and Pharmaceutical Bulletin. 2002; 50(6): 841–843.

19. Chaphalkar R, Apte KG, Talekar Y, Ojha SK, Nandave M. Antioxidants of Phyllanthus emblica L. Bark Extract Provide Hepatoprotection against Ethanol-Induced Hepatic Damage: A Comparison with Silymarin. Oxid Med Cell Longev. 2017; 2017: 3876040. doi: 10.1155/2017/3876040.

20. Saikat Gantait, Manisha Mahanta, Soumen Bera, Sandeep Kumar Verma. Biotech. 2021; 11(2): 62. https://doi.org/10.1007/s13205-020-02615-5

21. Halim B, Syahputra RA, Adenin I, Lubis HP, Mendrofa F, Lie S, Nugraha SE. Determination of phytochemical constituent, antioxidant activity, total phenol and total flavonoid of extract ethanol Phyllanthus emblica fruit. Pharmacognosy Journal. 2022; 14(1): 63-67.

22. Liu X, Cui C, Zhao M, Wang J, Luo W, Yang B, Jiang Y. Identification of phenolics in the fruit of emblica (Phyllanthus emblica L.) and their antioxidant activities. Food chemistry. 2008; 109(4): 909-15.

23. Sriwatcharakul S. Evaluation of bioactivities of Phyllanthus emblica seed. Energy Reports. 2020 Feb 1; 6:442-7.

24. Nambiar SS, Paramesha M, Shetty NP. Comparative analysis of phytochemical profile, antioxidant activities and foam prevention abilities of whole fruit, pulp and seeds of Emblica officinalis. Journal of Food Science and Technology. 2015 Nov; 52: 7254-62.

25. Balkrishna A, Verma S, Joshi M, Tomer M, Gohel V, Nain P, Dev R, Varshney A. Comprehensive phytochemical profiling of Phyllanthus emblica L. flowers on UHPLC/MS quadrupole time of flight, HPTLC, HPLC, and NMR analytical platforms reveals functional metabolites with potent anti-inflammatory effects in human (THP1) macrophages. Phytochemical Analysis. 2025 Jan.

26. Liu X, Zhao M, Wang J, Yang B, Jiang Y. Antioxidant activity of methanolic extract of emblica fruit (Phyllanthus emblica L.) from six regions in China. Journal of Food Composition and Analysis. 2008; 21(3): 219-28.

27. Tahir I, Khan MR, Shah NA, Aftab M. Evaluation of phytochemicals, antioxidant activity and amelioration of pulmonary fibrosis with Phyllanthus emblica leaves. BMC Complementary and Alternative Medicine. 2016 Dec; 16:1-2.

28. 28S. Shanthi, M. Sahina Begum, M.Senthuja. In- vitro Antioxidant and Anti-aging activity of a Traditional Ayurvedic Formulation. Research Journal of Pharmacy and Technology. 2023; 16(8): 3521-4. doi: 10.52711/0974-360X.2023.00581.

29. Moorthy SR, Kumar SS, Devandaran K, Anguchamy S, Ragunathan R, Johney J. Evaluation of the Antimicrobial, Antioxidant, and Cytotoxicity Against MCF-7 Breast Cancer Cell Lines of Phyllanthus emblica L. Bark Extract. Journal of Natural Remedies. 2024: 24(5): 1091-7.

30. Mahata S et al. Anticancer activity of Phyllanthus emblica Linn. (Indian gooseberry): inhibition of transcription factor AP-1 and HPV gene expression in cervical cancer cells. Nutrition and Cancer. 2013; 65(1): 88-97.

31. Zhang YJ, Nagao T, Tanaka T, Yang CR, Okabe H, Kouno I. Antiproliferative activity of the main constituents from Phyllanthus emblica. Biological and Pharmaceutical Bulletin. 2004; 27(2): 251-5.

32. Díaz-Herrera TH, Caldas Martínez ML, Coy-Barrera E. Phyllanthus-Derived Naturally-Occurring Products: An Overview of Their Effects against Viruses in Cell Models. Current Bioactive Compounds. 2024; 20(9): 1-26.

33. Lunavath V, Mamidala E. Studies on anti-HIV activity of Phyllanthus emblica plant extracts. The Bioscan. 2012; 7(3): 451-4.

34. Jeevangi S, Manjunath S, Sakhare PM. A study of anti-hyperlipidemia, hypolipidemic and anti-atherogenic activity of fruit of Emblica officinalis (amla) in high fat fed albino rats. International Journal of Medical Research and Health Sciences. 2013; 1(2): 70-7.

35. Variya BC, Bakrania AK, Chen Y, Han J, Patel SS. Suppression of abdominal fat and anti-hyperlipidemic potential of Emblica officinalis: Upregulation of PPARs and identification of active moiety. Biomedicine and Pharmacotherapy. 2018; 108: 1274-81.

36. Li W, Zhu HW, Chen YJ, Xiao H, Ge YZ, Hu HE, Li XL, Cao Y. Bioactivity‐guided isolation of anti‐inflammatory components from Phyllanthus emblica. Food Science and Nutrition. 2020; 8(6): 2670-9.

37. 37Sanakousar K. Patel, Arun K Shutter, Ria Patil, Archana Desangi, Vishalakshi Malali, Jyoti Patil, Sumangala Patil, Kusal K. Das, Prachi P. Parvatikar. In-Vitro Antioxidant, Anti-Inflammatory and Cytotoxic effects of different Solvent Extraction Terminalia chebula, Terminalia billerica, Phyllanthus emblica. Research Journal of Pharmacy and Technology. 2022; 15(7): 2940-4. doi: 10.52711/0974-360X.2022.00490

38. Srinivasan P, Vijayakumar S, Kothandaraman S, Palani M. Anti-diabetic activity of quercetin extracted from Phyllanthus emblica L. fruit: In silico and in vivo approaches. Journal of Pharmaceutical Analysis. 2018; 8(2):109-18.

39. Sultana Z, Jami SI, Ali E, Begum M, Haque M. Investigation of antidiabetic effect of ethanolic extract of Phyllanthus emblica Linn. fruits in experimental animal models. Pharmacology and Pharmacy. 2014;5(1):11-8.

40. Ayuwardani N, Sofro ZM, Fakhrudin N, Ikawati Z. Antioxidant and Neuroprotective Activities of Phyllanthus emblica L: A Review. Tropical Journal of Natural Product Research. 2024;8(10):8617-8628.

41. Spoorthi. N, Pinki Verma, Hemavathi. N. Amelioration of Antipsychotic Activity of Ethanolic Fruit Extract of Piper longum and its effects on TNF-α Expression in Rat Hippocampus. Research Journal of Pharmacy and Technology. 2024; 17(9):4214-0. doi: 10.52711/0974-360X.2024.00651

42. Jaijoy K, Soonthornchareonnon N, Lertprasertsuke N, Panthong A, Sireeratawong S. Acute and chronic oral toxicity of standardized water extract from the fruit of Phyllanthus emblica Linn. International Journal of Applied Research in Natural Products. 2010; 3(1): 48-58.

43. Prananda AT, Dalimunthe A, Harahap U, Simanjuntak Y, Peronika E, Karosekali NE, Hasibuan PAZ, Syahputra RA, Situmorang PC, Nurkolis F. Phyllanthus emblica: a comprehensive review of its phytochemical composition and pharmacological properties. Frontiers in Pharmacology. 2023; 14: 1288618. doi: 10.3389/fphar.2023.1288618. PMID: 37954853; PMCID: PMC10637531.

44. Priya FF, Islam MS. Phyllanthus emblica Linn. (Amla)—a natural gift to humans: an overview. Journal of Diseases and Medicinal Plants. 2019; 5:1-9.

45. Usharani P, Merugu PL, Nutalapati C. Evaluation of the effects of a standardized aqueous extract of Phyllanthus emblica fruits on endothelial dysfunction, oxidative stress, systemic inflammation and lipid profile in subjects with metabolic syndrome: A randomised, double blind, placebo controlled clinical study. BMC Complementary and Alternative Medicine.2019; 19: 1-8.

46. Charoenteeraboon J, Ngamkitidechakul C, Soonthornchareonnon N, Jaijoy K, Sireeratawong S. Antioxidant activities of the standardized water extract from fruit of Phyllanthus emblica Linn. Sonklanakarin Journal of Science and Technology. 2010; 32(6): 599-604.

47. 47.Jaijoy, K., et al. Anti-inflammatory and analgesic activities of the water extract from the fruit of Phyllanthus emblica Linn. International Journal of Applied Research in Natural Products. 2010: 28-35.

48. 48.Yin K, Li X, Luo X, Sha Y, Gong P, Gu J, Tan R. Hepatoprotective Effect and Potential Mechanism of Aqueous Extract from Phyllanthus emblica on Carbon‐ Tetrachloride‐Induced Liver Fibrosis in Rats. Evidence‐Based Complementary and Alternative Medicine. 2021; 2021(1): 5345821.

49. B Halim, RA Syahputra, I Adenin, HP Lubis, F Mendrofa, S Lie, SE Nugraha. Determination of phytochemical constituent, antioxidant activity, total phenol and total flavonoid of extract ethanol Phyllanthus emblica fruit. Pharmacognosy Journal. 2022; 14(1): 63-67. doi:10.5530/pj.2022.14.9

50. Jahan N, Akter S. Assessment of the antimicrobial activity of the ethanolic extract of Phyllanthus emblica in combination with different classes of antibiotics against single and multi-drug-resistant strains. Journal of Pharmacognosy and Phytochemistry. 2015; 4(4): 142-155.

51. Hemavathi N, Pinki Verma, Spoorthi N. Antidepressant and Antioxidant Activity of Ethanolic Extract of Evolvulus alsinoides Leaves and its effect on TNF-α Expression in Mice Hippocampus. Research Journal of Pharmacy and Technology. 2025; 18(4): 1551-6. doi: 10.52711/0974-360X.2025.

52. Rakesh Manna, Pinki Verma. A Review on Saraca indica – for Immunomodulatory Activity. Asian Journal of Pharmacy and Technology. 2023; 13(2): 135-8. doi: 10.52711/2231-5713.2023.00025

53. Hossain MM, Hamza A, Polash SA, Tushar MH, Takikawa M, Piash AB, Dekiwadia C, Saha T, Takeoka S, Sarker SR. Green synthesis of silver nanoparticles using Phyllanthus emblica extract: Investigation of antibacterial activity and biocompatibility in vivo. RSC Pharmaceutics. 2024; 1(2): 245-58.

54. Thoidingjam S, Tiku AB. Therapeutic efficacy of Phyllanthus emblica-coated iron oxide nanoparticles in A549 lung cancer cell line. Nanomedicine (Lond). 2019 Sep; 14(17): 2355-2371. doi: 10.2217/nnm-2019-0111. Epub 2019 Aug 15. PMID: 31414606.

55. Wang R, Xu X, Puja AM, Perumalsamy H, Balusamy SR, Kim H, Kim YJ. Gold Nanoparticles Prepared with Phyllanthus emblica Fruit Extract and Bifidobacterium animalis subsp. lactis Can Induce Apoptosis via Mitochondrial Impairment with Inhibition of Autophagy in the Human Gastric Carcinoma Cell Line AGS. Nanomaterials (Basel). 2021; 11(5): 1260. doi: 10.3390/nano11051260.

56. Ramezani, H., Sazegar, H. and Rouhi, L. Chitosan-casein as novel drug delivery system for transferring Phyllanthus emblica to inhibit Pseudomonas aeruginosa. BMC Biotechnology. 2024; 24: 101. https://doi.org/10.1186/s12896-024-00907-9.

57. Masfria, Sumaiyah, syahputra, h., and silvia. Antibacterial and anti-inflammatory activities of nanosimplicia phyllantus emblica l. fruit in suspension formulation. International Journal of Applied Pharmaceutics. 2025; 17(2); 376–383. https://doi.org/10.22159/ijap.2025v17i2.52608.

58. G. Patel, R. Sorake and N. Pai A Randomized Single Blind Placebo Controlled Clinical Study to Evaluate Efficacy of Amalaki (Emblica Officinalis) Extract Capsule on Acne Vulgaris Along with Its anti-oxidant Property. International Journal OF Pharmaceutical Sciences and Research. 2021; 12(7): 3832-3838. doi: 10.13040/IJPSR.0975-8232.12(7).3832-38

59. Acampado LRT, Chiu HHC, Larrazabal RB Jr, Arcellana AES, Añonuevo-Cruz MCS. The Efficacy and Safety of Emblica officinalis Aqueous Fruit Extract among Adult Patients with Dyslipidemia: A Systematic Review and Meta-analysis. Acta Med Philipp.2023 ;29; 57(5): 90-95. doi: 10.47895/amp.vi0.5047.

60. Usharani P, Fatima N, Muralidhar N. Effects of Phyllanthus emblica extract on endothelial dysfunction and biomarkers of oxidative stress in patients with type 2 diabetes mellitus: a randomized, double-blind, controlled study. Diabetes Metab Syndr Obes. 2013; 26(6): 275-84. doi: 10.2147/DMSO.S46341.

61. Prananda AT, Dalimunthe A, Harahap U, Simanjuntak Y, Peronika E, Karosekali NE, Hasibuan PAZ, Syahputra RA, Situmorang PC, Nurkolis F. Phyllanthus emblica: a comprehensive review of its phytochemical composition and pharmacological properties. Front Pharmacol. 2023; 14: 1-20. doi:10.3389/fphar.2023.1288618.

62. Geethika, E., Ramamoorthy, S. and Ravikanth, G. Does long-term harvesting impact genetic diversity and population genetic structure? A study of Indian gooseberry (Phyllanthus emblica) in the Central Western Ghats region in India. Plant Syst Evol. 2024; 310.https://doi.org/10.1007/s00606-024-01906-1.

63. Tiejun Zhao et al, Anticancer Properties of Phyllanthus emblica (Indian Gooseberry) Hindawi Publishing Corporation Oxidative Medicine and Cellular Longevity. 2015; 1-7. http://dx.doi.org/10.1155/2015/950890.

64. Tiana M, Kusuma ASW, Shanmuganathan K. Antibacterial activity of Phyllanthus emblica against Bacillus cereus and Shigella dysenteriae. Asian J Pharm Clin Res. 2017.

65. Masfria S, Sumaiyah, Hafid Syahputra, Silvia. Antibacterial and anti-inflammatory activities of nanosimplicia Phyllanthus emblica L. fruit in suspension formulation. Int J Appl Pharm. 2025.

66. Raj M, Vyas GK, Sharma S, Sharma A. Phytoanalysis and formulation of herbal lotion containing Phyllanthus emblica. Asian J Pharm Res Dev. 2022.

67. Chaiyasut C, Sivamaruthi BS, et al. Assessment of the biological safety of fermented Phyllanthus emblica fruit juice. Asian J Pharm Clin Res. 2018.

68. Md Monir Hossain et al]. Green synthesis of silver nanoparticles using Phyllanthus emblica extract: investigation of antibacterial and antifungal activity. Int J Appl Pharm. 2024; 16(2): 1-6..

69. Masihuddin; Jafri MA; Siddiqui A; Chaudhary S. Traditional uses, phytochemistry, and pharmacological activities of amla with special reference of Unani medicine: an updated review. Asian J Pharm Clin Res. 2019; 12(2): 70–74. doi:10.22159/ajpcr. 2019.v12i2.29178.

70. Pawar DB, et al. Antidepressant activity of aqueous extracts of fruits of Terminalia chebula and Phyllanthus emblica. Int J Pharm Pharm Sci. 2014.

71. Bhandari PR, Kamdod MA. Emblica officinalis (Amla): a review of potential therapeutic applications. Int J Green Pharm. 2012; 6(4): 257–269. doi:10.4103/0973-8258.108204

72. Hassan SM, Mughal SS, Aslam A, Mushtaq M, Munir M, Pervez S, Shabbir N, Ayub AR, Farman M. Emblica officinalis (Amla): A prospective review on distinctive properties and therapeutic applications of Amla. Innovare J Ayurvedic Sci. 2020; 8(3): 1–6.

Received on 01.08.2025 Revised on 22.11.2025

Accepted on 23.01.2026 Published on 15.04.2026

Available online from April 18, 2026

Asian J. Pharm. Res. 2026; 16(2):163-172.

DOI: 10.52711/2231-5691.2026.00025

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License.

AuNPs that were green-synthesised with P. emblica plus Through autophagy suppression and mitochondrial malfunction, Bifidobacterium lactis causes AGS gastric cancer cells to undergo apoptosis.55

4. Polymeric and Lipid Nanoformulations: Nano‑Simplicial and Chitosan-Based Systems:

ACKNOWLEDGMENT:

CONFLICT OF INTEREST:

AuNPs that were green-synthesised with P. emblica plus Through autophagy suppression and mitochondrial malfunction, Bifidobacterium lactis causes AGS gastric cancer cells to undergo apoptosis.⁵⁵